Lidocaína Aguettant

Lidocaine, the active ingredient in Lidocaína Aguettant, is a local anesthetic presented as a sterile solution for infiltration, intradermal and subcutaneous use. It provides temporary loss of sensation in targeted tissues for minor surgical, diagnostic and cosmetic procedures, and is indicated for adult patients where rapid onset and short duration of anesthesia are required.

GNH USA supplies Lidocaína Aguettant as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product conforms to EU quality standards and is distributed under strict regulatory oversight.

Lidocaine is a local anesthetic used to achieve temporary loss of sensation in specific tissues.

- Infiltration procedures: provides local anesthesia for minor surgical or diagnostic interventions performed by injecting directly into the tissue. - Intradermal applications: creates surface anesthesia for skin testing, minor dermatologic procedures, or superficial lesion removal. - Subcutaneous injections: numbs the area beneath the skin to facilitate painless delivery of medications or minor surgical excisions.

Lidocaine may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Burning or stinging at the injection site. - Redness or mild swelling around the administration area. - Dizziness or light‑headedness. - Nausea or mild headache.

Serious or Rare Side Effects: - Cardiovascular collapse or severe hypotension. - Central nervous system toxicity presenting as seizures or altered consciousness. - Allergic reactions such as rash, angioedema, or anaphylaxis.

When using Lidocaína Aguettant, several safety considerations should be observed. - Patient assessment: evaluate medical history for cardiac, hepatic or renal disease before administration. - Dose calculation: adjust dose based on patient weight, age and procedure extent. - Monitoring: observe vital signs and neurological status during and after injection. - Contraindications: avoid use in patients with known hypersensitivity to amide‑type local anesthetics. - Drug interactions: review concomitant medications that may potentiate systemic toxicity. - Store at ambient temperature: keep in original container, protect from light and moisture.

Lidocaine can interact with other medicines, influencing its safety and effectiveness.

Major Interactions (Avoid): - Class I antiarrhythmic agents (e.g., quinidine, procainamide): combined use may cause severe cardiac conduction disturbances. - Monoamine oxidase inhibitors (MAOIs): concurrent administration can increase the risk of systemic toxicity.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may enhance lidocaine’s cardiac depressant effects, requiring careful monitoring. - CYP3A4 inhibitors (e.g., erythromycin, ketoconazole): can raise plasma lidocaine levels, increasing toxicity risk. - Central nervous system depressants (e.g., benzodiazepines, opioids): may potentiate CNS side effects such as dizziness or seizures.